For this reason, inhibiting PARP activity, especially PARP-1, with small molecules reduces repair of ssDNA breaks, and is likely to be useful for treating cancers, stress, inflammatory responses and cardiovascular disease [7], [8]. The gene discussed is PARP1; the disease is cancer.